Patent · US Active

Aminoindazolylurea derivatives

US8207210B2 · kind B2 · utility

0Cited by

0References

2Claims

0Family size

Assignee

Merck Patent GmbH · DE

Inventors

Markus Klein · Weiterstadt, DE
Rolf Gericke · Seeheim-Jugenheim, DE
Norbert Beier · Reinheim, DE
Florian Lang · Gilching, DE

Key dates

Filing date	Jun 18, 2007
Grant date	Jun 26, 2012
Priority date	—
Expiry date	Mar 22, 2028

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P43/00
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Novel aminoindazolylurea derivatives of the formula I (I), in which R1, R2, R3, R4, R5, X and Y have the meanings indicated in Claim 1, are SGK inhibitors and can be used for the treatment of SGK-induced diseases and complaints, such as diabetes, obesity, metabolic syndrome (dyslipidaemia), systemic and pulmonary hypertonia, cardiovascular diseases and kidney diseases, generally in fibroses and inflammatory processes of any type.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.